Company news

Share this article:
Validus Pharmaceuticals announced that it has acquired bipolar disorder treatment Equetro (carbamazepine) extended release capsules from Shire. Validus Pharmaceuticals will begin active promotion of Equetro during the US Psychiatric & Mental Health Congress in Orlando, FL, in early October.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

FDA wants Alexion to clean up

FDA inspectors have cited the manufacturer of the rare-disease drug Soliris (eculizumab) for poor manufacturing practices.

Painkiller maker Acura gets NIH grant

The $300,000 grant will go towards an abuse-deterrent technology.

Biologics have higher psoriatic arthritis adherence

A study of psoriatic arthritis patients found greater adherence among patients whose initial treatment was a biologic, compared to those who started with a non-biologic treatment.